<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>MRK on ratiertm</title><link>http://ratiertm.github.io/tags/mrk/</link><description>Recent content in MRK on ratiertm</description><generator>Hugo -- gohugo.io</generator><language>ko</language><copyright>© 2026 마인드빌드</copyright><lastBuildDate>Mon, 02 Feb 2026 00:00:00 +0000</lastBuildDate><atom:link href="http://ratiertm.github.io/tags/mrk/index.xml" rel="self" type="application/rss+xml"/><item><title>머크(MRK) 주가 전망: 키트루다 특허 만료 공포, 정말 팔아야 할까?</title><link>http://ratiertm.github.io/posts/merck-mrk-stock-analysis-2026/</link><pubDate>Mon, 02 Feb 2026 00:00:00 +0000</pubDate><guid>http://ratiertm.github.io/posts/merck-mrk-stock-analysis-2026/</guid><description>&lt;h1 class="relative group"&gt;머크(MRK) 주가 전망: 키트루다 특허 만료 공포, 정말 팔아야 할까?
 &lt;div id="머크mrk-주가-전망-키트루다-특허-만료-공포-정말-팔아야-할까" class="anchor"&gt;&lt;/div&gt;
 
 &lt;span
 class="absolute top-0 w-6 transition-opacity opacity-0 -start-6 not-prose group-hover:opacity-100 select-none"&gt;
 &lt;a class="text-primary-300 dark:text-neutral-700 !no-underline" href="#%eb%a8%b8%ed%81%acmrk-%ec%a3%bc%ea%b0%80-%ec%a0%84%eb%a7%9d-%ed%82%a4%ed%8a%b8%eb%a3%a8%eb%8b%a4-%ed%8a%b9%ed%97%88-%eb%a7%8c%eb%a3%8c-%ea%b3%b5%ed%8f%ac-%ec%a0%95%eb%a7%90-%ed%8c%94%ec%95%84%ec%95%bc-%ed%95%a0%ea%b9%8c" aria-label="앵커"&gt;#&lt;/a&gt;
 &lt;/span&gt;
 
&lt;/h1&gt;
&lt;p&gt;&lt;figure&gt;&lt;img
 class="my-0 rounded-md"
 loading="lazy"
 decoding="async"
 fetchpriority="low"
 alt="MRK 주가 차트"
 src="../images/MRK.webp"
 &gt;&lt;/figure&gt;
&lt;/p&gt;
&lt;p&gt;&amp;ldquo;키트루다 특허 2028년에 만료되는데, 머크 사도 돼요?&amp;rdquo;&lt;/p&gt;</description></item><item><title>머크 vs J&amp;J: 2026년 제약주 승자는 누구? 배당왕과 항암제 1위의 대결</title><link>http://ratiertm.github.io/posts/merck-vs-jnj-pharma-comparison-2026/</link><pubDate>Thu, 22 Jan 2026 00:00:00 +0000</pubDate><guid>http://ratiertm.github.io/posts/merck-vs-jnj-pharma-comparison-2026/</guid><description>&lt;p&gt;&lt;figure&gt;&lt;img
 class="my-0 rounded-md"
 loading="lazy"
 decoding="async"
 fetchpriority="low"
 alt="머크 vs J&amp;amp;J 제약주 비교"
 src="http://ratiertm.github.io/images/mrk-jnj-comparison.jpg"
 &gt;&lt;/figure&gt;
&lt;/p&gt;
&lt;p&gt;54년 연속 배당 인상. 미국에서 딱 2개 기업만 가진 AAA 신용등급.&lt;/p&gt;
&lt;p&gt;이게 존슨앤존슨(JNJ) 얘기예요.&lt;/p&gt;
&lt;p&gt;반면 머크(MRK)는요? 항암제 Keytruda 하나로 연 29조 원을 벌어들이는 회사죠.&lt;/p&gt;</description></item></channel></rss>